This therapeutic potential of GSK‐3β inhibitors has made them a significant research area.[10] In addition, several studies have demonstrated that inhibition of GSK‐3β, which has a therapeutic effect against 25 different cancer cells, protects normal cells and tissues from the harmful effects of cancer treatments.[11] Several studies have reported overexpression of various protein kinases in primary and metastatic breast cancers. The gene discussed is GSK3B; the disease is breast carcinoma.